Next Article in Journal
Body Fluid Identification in Samples Collected after Intimate and Social Contact: A Comparison of Two mRNA Profiling Methods and the Additional Information Gained by cSNP Genotypes
Next Article in Special Issue
Rare 15q21.1q22.31 Duplication Due to a Familial Chromosomal Insertion and Diagnostic Investigation in a Carrier of Balanced Chromosomal Rearrangement and Intellectual Disability
Previous Article in Journal
CNN_FunBar: Advanced Learning Technique for Fungi ITS Region Classification
Previous Article in Special Issue
Challenges and Opportunities for Clinical Cytogenetics in the 21st Century
 
 
Case Report
Peer-Review Record

Familial 4p Interstitial Deletion Provides New Insights and Candidate Genes Underlying This Rare Condition

by Jing Di 1,†, Leonard Yenwongfai 1,†, Hillary T. Rieger 2, Shulin Zhang 1 and Sainan Wei 1,*
Reviewer 1:
Submission received: 16 February 2023 / Revised: 27 February 2023 / Accepted: 1 March 2023 / Published: 3 March 2023
(This article belongs to the Special Issue Advances in Clinical Cytogenetics)

Round 1

Reviewer 1 Report

This manuscript is well-written and highly clinically relevant. It provided important information and added our understanding for the 4p interstitial deletion associated conditions. There are a few minor points to be addressed:

1. I understand that for this rare condition, most of published papers only have conventional cytogenetics done, but for those did have microarray results, it will be beneficial to compare the findings especially genes involved with the current study and do genotype-phenotype correlation, if possible, to highlight the critical region/genes.  At least, give some discussion addressing such previous publications.

2. Need to be carefully check ISCN for karyotype throughout the manuscript, to be consistent whether is by ISCN2016 or 2020. If 4p banding is from pter to centromere, it is following ISCN2020. 

Author Response

Dear reviewer,

Thank you for your valuable feedback. We have taken your comments into consideration and made the following changes:

This manuscript is well-written and highly clinically relevant. It provided important information and added our understanding for the 4p interstitial deletion associated conditions. There are a few minor points to be addressed:

1. I understand that for this rare condition, most of published papers only have conventional cytogenetics done, but for those did have microarray results, it will be beneficial to compare the findings especially genes involved with the current study and do genotype-phenotype correlation, if possible, to highlight the critical region/genes.  At least, give some discussion addressing such previous publications.

Response 1: Thank you for the comments! We have discussed and addressed the correlations with previous publications between line 147 to 158: To our knowledge, there have been only two reported instances of familial interstitial 4p deletion, both of which were identified by conventional chromosome analyses[3,7]. A more detailed illustration of the genes implicated in the deleted region would improve our understanding of the correlation between genotype and phenotype. Recent reports have identified de novo interstitial 4p deletions using CMA and conventional G-banding cytogenetics similar to the methods used in our study. Mitroi et al. [13]and Park et al. [17]identified de novo 4p interstitial deletions in a proband with intellectual disability, mild dysmorphic features, and mild hypotonia, similar to our case. The authors speculated that SLIT2, KCNIP4, RBPJ, and LG12 genes are involved in neurologic development and skeletal abnormalities. The genes identified in our study significantly overlap with previous studies, however, we did not identify SLIT2 and KCNIP4 genes in the deleted 4p region. The variation in methodology employed across different studies may, to some extent, account for the discrepancy." 

We also summarized the comparisons in a table for your reference:

Paper

Genes involved (CMA)

Phenotype observed

Jing et al -2023

PPARGC1A, DHX15, SOD3, LG12, SEPSECS, P14K2B, ZCCHC4, ANAPC4, SLC34A2, RBPJ, CCKAR, PCDH7, STIM2, SMIM20, ARAP2, DTHD1

 

Genes in yellow were the common genes found in both studies.

 

Method:

13.4 Mb deletion

Affymetrix; Thermo Fisher Scientific, Inc., Waltham, MA, USA

Thin and small head, large ears, long eye lashes, upward-slanting eye openings, low nasal bridge, broad nostrils, heart shaped upper lip, grooved philtrum, slightly enlarged tongue.

Park et al-2020

Male

De novo interstitial 4p deletion

19 genes

SLIT2, MIR218-1, KCNIP4

ADGRA3, GBA3, PPARGC1A, DHX15, SOD3, LGI2, SEPSECS, PI4K2B, ZCCHC4, ANAPC4, SLC34A2, SMIM20, RBPJ, CCKAR, STIM2, and PCDH7

 

Genes in red, highly expressed in brain tissue with potential roles in neurodevelopment.

 

Method:

12 Mb deletion

CytoScan 750K chromo­somal microarray (Affymetrix, Santa Clara, CA, USA)

Tall, thin body, Hypotonia, mental retardation, hypertelorism

Mitroi et al- 2017

De novo interstitial 4p deletion

SLIT2, KCNIP4,

 MIR 218–1, GPR125, GBA3, PPARGC1A, DHX15, SOD3, LGI2, SEPSECS, P14K2B, ZCCHC4, ANAPC4, SLC34A2, RBPJ, CCKAR, PCDH7, STIM2,

 

Method used:

13.34 Mb

Agilent Sure

Print G3 Human Genome CGH+SNP, 4_180K, Microarray Kit

Long face with a high forehead, deep-set eyes, puffy

eyelids, broad andflat nasal bridge, lateralflaring of the nostrils, long philtrum, and a thick and proeminent lower lip

His skin showed one café-au-lait spot. His ears consisted of proeminent and thick lobes, and they were very close to his head. He had pectus excavatum,

broad hands and feet, and clinodactyly of the toes

2. Need to be carefully check ISCN for karyotype throughout the manuscript, to be consistent whether is by ISCN2016 or 2020. If 4p banding is from pter to centromere, it is following ISCN2020. 

Response 2: Thank you for the comments! This has been revised in compliance of ISCN 2020.

Author Response File: Author Response.docx

Reviewer 2 Report

I read with interest the manuscript. This case report is well written and informative.

I believe it deserves consideration for publication after a few minor revisions.

Please find here my comments:

 

All genes name should  be italic.

 

Could authors offer more information regarding prenatal and neonatal  history of the reported case and try to correlate with the genotype based on literature data?

 

Could authors offer information about cerebral MRI assessment of the reported case?

 

 

Rows 116, 122  - Use intellectual disability instead of mental retardation

Row 154 - Replace retardation with delay

 

 

 

Author Response

Dear reviewer,

Thank you for your valuable feedback. We have taken your comments into consideration and made the following changes:

I read with interest the manuscript. This case report is well written and informative.

I believe it deserves consideration for publication after a few minor revisions.

Please find here my comments:

 

1. All genes name should  be italic.

Response 1: Thank you for bringing this to our attention! We have made the necessary updates and all gene names are now in italics.

2. Could authors offer more information regarding prenatal and neonatal  history of the reported case and try to correlate with the genotype based on literature data?

Response 3: Thank you for your comment. However, the reported case was not born in our institution, and as a result, we are unable to obtain the prenatal and neonatal history of the reported case. 

3. Could authors offer information about cerebral MRI assessment of the reported case?

Response 3: Thank you for your comment. However, we would like to clarify that there is no record of an MRI assessment for the reported case.

 

Rows 116, 122  - Use intellectual disability instead of mental retardation

Response: All mental retardation have been replaced with intellectual disability.

Row 154 - Replace retardation with delay

Response: Retardation has been replaced wtih delay.

Back to TopTop